Ozempic found to slash risk of disease affecting 6.7m Americans Weight-loss GLP-1 drugs like Ozempic could be an effective ...

For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause mortality compared with other ...

Binge eating disorder is strongly associated with weight gain and obesity, though not all individuals with obesity have BED.

A groundbreaking study has revealed that GLP-1 receptor agonists—including popular weight-loss and diabetes drugs like ...

Neuroscientist Sabina Brennan encourages caregivers to live in the moment and notice the happy experiences they share with ...

Key messages • It is known that older people who take more medicines with an anticholinergic effect may be at greater risk of cognitive decline. • There is a lack of high-quality evidence to show ...

Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...

Results from this study show that there is a direct correlation between the use of anti-obesity medications and testosterone levels,” the study author said.

It may be possible to detect Alzheimer’s risk sooner—as early as your 20s Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers ...